- Argentina
- Australia
- Austria
- Bangladesh
- Belgium
- Botswana
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Cuba
- Czech Republic
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Zimbabwe
Kenya Health News API
Get the live top health headlines from Kenya with our JSON API.
Get API key for the Kenya Health News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from Kenya.
GET
https://gnews.io/api/v4/top-headlines?country=ke&category=health&apikey=API_KEY
{
"totalArticles": 6404,
"articles": [
{
"id": "8da96e7a751920449e2ddb21e23119de",
"title": "Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control",
"description": "ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen",
"content": "NEW ORLEANS -- Once-daily orforglipron (Foundayo) improved outcomes in adults with type 2 diabetes and inadequate glycemic control, the international ACHIEVE-5 trial showed.\nIn patients already taking background insulin glargine, glycemic control was... [5134 chars]",
"url": "https://www.medpagetoday.com/meetingcoverage/ada/121628",
"image": "https://assets.medpagetoday.net/media/images/121xxx/121628.jpg",
"publishedAt": "2026-06-07T20:17:01Z",
"lang": "en",
"source": {
"id": "572d25e23e12ec1560e8ee1884a7057a",
"name": "MedPage Today",
"url": "https://www.medpagetoday.com"
}
},
{
"id": "c0bca22153fd695181dd0239cfbb4155",
"title": "Risk of complications in adulthood following childhood metabolic dysfunction-associated steatohepatitis based on Korean national health insurance data",
"description": "The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), which can be complicated by metabolic dysfunction-associated steatohepatitis (MASH), is increasing worldwide. This study aimed to determine the risk of complications occurring in adulthood due to childhood MASH. This matched cohort study enrolled 12,894 children and adolescents aged between 7 and 18 years registered with the Korean National Health Insurance Service Database for the period 2002–2021. MASH was defined by the diagnostic code K75.8 before 19 years of age. The control group enrolled patients without MASH. The MASH and non-MASH population were matched 1:5. Among 12,894 MASH patients and 921,141 non-MASH patients, we analyzed the frequency of complications for 1–10 years, starting from 19 years of age, and medical costs, The MASH group had a higher hazard ratio of complications than the non-MASH group in adulthood, including liver fibrosis and cirrhosis, hypertensive disease, hyperlipidemia, diabetes, cancer, and mental illness. In addition, patients in the MASH group had higher medical costs than patients in the non-MASH group for other diseases, including for cerebrovascular and liver fibrosis. Children with MASH are at an increased risk of various complications in adulthood, inflicting a significant medical burden, necessitating more active management and intervention.",
"content": "Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give... [797 chars]",
"url": "https://www.nature.com/articles/s41598-025-97229-3?error=cookies_not_supported&code=2082769e-4562-4572-a7c9-c4052aa0485c",
"image": "https://www.nature.com/static/images/favicons/nature/favicon-48x48-b52890008c.png",
"publishedAt": "2026-06-07T19:40:03Z",
"lang": "en",
"source": {
"id": "7abf0df285fbe93cdccffcc7c4088737",
"name": "Nature",
"url": "https://www.nature.com"
}
},
{
"id": "aaea88b757864ae56e756036da53032b",
"title": "Scientists Reveal a Novel Layer of Gene Regulation in the Heart",
"description": "The heart is able to adapt to changing conditions and demands by using a molecular mechanism known as alternative splicing. Cells modify ... | Genetics And Genomics",
"content": "The heart is able to adapt to changing conditions and demands by using a molecular mechanism known as alternative splicing. Cells modify active genes; when those genes are transcribed into RNA molecules, the RNA is processed and edited before being m... [2567 chars]",
"url": "https://www.labroots.com/trending/genetics-and-genomics/30635/scientists-reveal-novel-layer-gene-regulation-heart",
"image": "https://images.labroots.com/content_article_profile_image_e2bbd290c3fb23c02e2c845094ad29a15f7ae0f0_1651.jpg",
"publishedAt": "2026-06-07T17:46:00Z",
"lang": "en",
"source": {
"id": "8d5f55fed03d0b9ad7b7af5667e60497",
"name": "Labroots",
"url": "https://www.labroots.com"
}
}
]
}